4CPS-095 Drug-drug interactions among hepatitis c patients treated with direct-acting antivirals

BACKGROUND: Interferon-free combination direct-acting antivirals (DAAs) regimens have improved tolerability and efficacy for HCV-infected patients but it is necesary to check drug-drug interactions (DDIs) because they have the potential to cause toxicity or loss of efficacy to treat HCV. PURPOSE: To...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Vargas, B Rodriguez, Garcia, E Matilla, Fernández, C Apezteguía, Sanz, MP Bautista, del Hoyo, L Esteban, Garcia, I Santaolalla, Diaz, R Moreno
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 4: Clinical pharmacy services
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535731/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.186
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars